Syncope Trial to Understand Tilt Testing or ECG Recording Tenth Prevention of Syncope Trial

NARecruitingINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Syncope
Interventions
DIAGNOSTIC_TEST

Diagnostic Test: Head Up Tilt Table (HUT)

"Participant randomized to open-label diagnostic strategy. Results and all follow-up care to be in the hands of treating cardiologist as this is a pragmatic study.~the early HUT \[protocol: supine pre-tilt phase 5 min, un-medicated HUT to 70 degrees for 20 minutes; if response negative then 400 μg of sublingual nitroglycerin and continued 70 degree tilt for 20 minutes\]"

DEVICE

Device: Implantable Loop Recorder

ILR is a small subcutaneously implanted device, lasting up to 3 years, that records heart rhythms, and which may be either auto-triggered or patientactivated.

Trial Locations (1)

T2N 4Z6

RECRUITING

University of Calgary, Calgary

All Listed Sponsors
lead

University of Calgary

OTHER